Troubled pharmaceutical company Valeant Pharmaceuticals Intl Inc (NYSE: VRX) announced on Friday pricing for its SILIQ (brodalumab) injection.
April 21, 2017 at 06:05PM
from Jayson Derrick
Featured Post
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment